Literature DB >> 35849169

DIA-based proteomics analysis of serum-derived exosomal proteins as potential candidate biomarkers for intrahepatic cholestasis in pregnancy.

Liju Nie1, Siming Xin1, Jiusheng Zheng1, Yong Luo2, Yang Zou2, Xianxian Liu2, Huayan Chen1, Xiaozhen Lei1, Xiaoming Zeng3, Hua Lai4.   

Abstract

BACKGROUND: Data-independent acquisition (DIA) is one of the most powerful and reproducible proteomic technologies for large-scale digital qualitative and quantitative research. The aim of this study was to use proteomic methodologies for the identification of biomarkers that are over or underexpressed in women with intrahepatic cholestasis of pregnancy (ICP) compared with controls and discover a potential biomarker panel for ICP detection.
METHODS: The participants included 11 ICP patients and 11 healthy pregnant women as controls. The clinical characteristic data and the laboratory biochemical data were collected at the time of recruitment. Then, a data-independent acquisition (DIA)-based proteomics approach was used to identify differentially expressed proteins (DEPs) in serum exosomes between ICP patients and controls. Finally, bioinformatics analysis was used to identify the relevant processes in which these DEPs were involved.
RESULTS: The proteomics results showed that there were 162 DEPs in serum exosomes between pregnant women with ICP and healthy pregnant women, of which 106 were upregulated and 56 were downregulated in ICP. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis showed that the identified proteins were functionally related to specific cell processes including apoptosis, lipid metabolism, immune response and cell proliferation, and metabolic disorders, suggesting that these may be primary causative factors in ICP pathogenesis. Meanwhile, complement and coagulation cascades may be closely related to the development of ICP. Receiver operating characteristic curve (ROC) analysis showed that the area under the curve values of Elongation factor 1-alpha 1, Beta-2-glycoprotein I, Zinc finger protein 238, CP protein and Ficolin-3 were all approximately 0.9, indicating the promising diagnostic value of these proteins.
CONCLUSIONS: This preliminary work provides a better understanding of the proteomic alterations in the serum exosomes of pregnant women with ICP.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Biomarkers; DIA; ICP; Proteome changes; Proteomics analysis

Year:  2022        PMID: 35849169     DOI: 10.1007/s00404-022-06703-0

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.493


  33 in total

Review 1.  New Insights on Intrahepatic Cholestasis of Pregnancy.

Authors:  Annarosa Floreani; Maria Teresa Gervasi
Journal:  Clin Liver Dis       Date:  2015-10-09       Impact factor: 6.126

Review 2.  Intrahepatic Cholestasis of Pregnancy.

Authors:  Devin D Smith; Kara M Rood
Journal:  Clin Obstet Gynecol       Date:  2020-03       Impact factor: 2.190

3.  Management of intrahepatic cholestasis in pregnancy.

Authors:  Kirsten R Palmer; Liu Xiaohua; Ben W Mol
Journal:  Lancet       Date:  2019-02-14       Impact factor: 79.321

Review 4.  Review of a challenging clinical issue: Intrahepatic cholestasis of pregnancy.

Authors:  Sebiha Ozkan; Yasin Ceylan; Orhan Veli Ozkan; Sule Yildirim
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

Review 5.  The pathophysiology of intrahepatic cholestasis of pregnancy.

Authors:  Peter H Dixon; Catherine Williamson
Journal:  Clin Res Hepatol Gastroenterol       Date:  2016-01-25       Impact factor: 2.947

6.  Fetal outcomes in pregnancies complicated by intrahepatic cholestasis of pregnancy in a Northern California cohort.

Authors:  Michelle Rook; Juan Vargas; Aaron Caughey; Peter Bacchetti; Philip Rosenthal; Laura Bull
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

7.  Feasibility of urinary microRNA profiling detection in intrahepatic cholestasis of pregnancy and its potential as a non-invasive biomarker.

Authors:  Li Ma; Xiao-Qing Zhang; Da-Xue Zhou; Yue Cui; Lin-Lin Deng; Ting Yang; Yong Shao; Min Ding
Journal:  Sci Rep       Date:  2016-08-18       Impact factor: 4.379

8.  Bile Acid Determination after Standardized Glucose Load in Pregnant Women.

Authors:  April Adams; Katherine Jacobs; Rachel Isaksson Vogel; Virginia Lupo
Journal:  AJP Rep       Date:  2015-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.